Antibiotic resistant infections due to Streptococcus pneumoniae: Impact on therapeutic options and clinical outcome

Keyphrases

• Therapeutic Potential 100%
• Antibiotic Resistance 100%
• Clinical Outcomes 100%
• Multidrug-resistant Infection 100%
• Streptococcus Pneumoniae 100%
• Pediatric Population 66%
• Conjugate Pneumococcal Vaccine 66%
• Pneumococcal Isolates 66%
• Response to Therapy 33%
• Antibiotics 33%
• Multiple Classes 33%
• Effective Means 33%
• Treatment Failure 33%
• Antibiotic Use 33%
• Broad-spectrum Antibiotics 33%
• Infection Treatment 33%
• Therapy Outcome 33%
• Antibiotic Agents 33%
• Invasive Pneumococcal Disease 33%
• Pneumococcal Infections 33%
• β-lactam Antibiotics 33%
• Population Decline 33%
• Educational Intervention Programme 33%
• Intermediate Resistance 33%
• Children under 5 Years 33%
• Susceptible Strain 33%
• Pneumococcal Disease 33%

Medicine and Dentistry

• Infection 100%
• Pneumococcal Pneumonia 100%
• Streptococcus Pneumonia 100%
• Antibiotic Resistance 50%
• Pneumococcal Infection 33%
• Pneumococcus Vaccine 33%
• Pediatrics 33%
• Prevalence 16%
• Broad-Spectrum Antibiotic 16%
• β-Lactam antibiotic 16%
• Antibiotics 16%
• Antimicrobial Agent 16%
• Diseases 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Streptococcus Pneumonia 100%
• Antimicrobial Resistance 50%
• Pneumococcus Vaccine 33%
• Pneumococcal Infection 33%
• Antibiotics 16%
• Antibiotic Agent 16%
• Prevalence 16%
• Beta Lactam Antibiotic 16%
• Antimicrobial Agent 16%
• Diseases 16%